Search

Your search keyword '"Mitrečić, Dinko"' showing total 292 results

Search Constraints

Start Over You searched for: Author "Mitrečić, Dinko" Remove constraint Author: "Mitrečić, Dinko"
292 results on '"Mitrečić, Dinko"'

Search Results

4. Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels

6. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

7. Transplantation of neural stem cells improves recovery of stroke-affected mice and induces cell-specific changes in GSDMD and MLKL expression.

10. Analysis of grafted Thy1-YFP-16 positive cells in mouse brains affected by ischaemic stroke

11. Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis

15. Pulsating Extremely Low-Frequency Electromagnetic Fields Influence Differentiation of Mouse Neural Stem Cells towards Astrocyte-like Phenotypes: In Vitro Pilot Study.

17. Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

19. Tapping the potential of bone regeneration by delivery of concentrated extracellular vesicles to the fracture site: A new horizon in bone regeneration therapy research?

24. Human Oral Mucosa Stem Cells Increase Survival of Neurons Affected by In Vitro Anoxia and Improve Recovery of Mice Affected by Stroke Through Time-limited Secretion of miR-514A-3p

25. Human cellular modelling and genetic dissection of the trisomy 21 effects on early brain development

26. Regenerative neurology and regenerative cardiology: Shared hurdles and achievements

29. Cerebral organoids: in vitro model for brain development and neurodegeneration

30. Down syndrome biological age is accelerated on average by 19 years, beginning in early childhood, independent of co-morbidities, and trisomy of Down-syndrome-critical-region is a sufficient trigger

31. N-Glycosylation of induced Pluripotent Stem Cells (iPSCs) and Neural Stem Cells (NSC) derived from Person with Down Syndrome (DS) caused by Trisomy 21 (T21)

32. Toll-like receptor 2 deficiency is associated with specific alterations of synaptic proteome

33. Regenerative Neurology and Regenerative Cardiology: Shared Hurdles and Achievements

34. Diaminocyclopentane-derived O-GlcNAcase inhibitors for combating tau hyperphosphorylation in Alzheimer's disease

38. Plasma membrane Ca2+ ATPase expression and activity in Toll-like receptor 2 deficient mice

39. Toll-like receptor 2 deficiency affects neuroplastin and P-type ATPases expression in mouse brain

41. Policy Paper on Healthy Ageing – BFHA2020 Conference

47. Tracking immunohistochemical neuroplastin expression in Toll-like receptor 2 deficient mice

49. The expression of neuroplastin, calcium ATPase and sodium/potassium ATPase in the brain of mice lacking Toll-like receptor 2

Catalog

Books, media, physical & digital resources